Schedule 13G ownership disclosure
IMMUNOMEDICS INC
Security class unavailable · CUSIP: 452907108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,950,373
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-20-000245
- Form type
- SC 13G
- Filer
- IMMUNOMEDICS INC
- CIK
- CIK 722830
- Filed
- Apr 16, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership